Nicotine 7mg/24hr, 14mg/24hr, 21mg/24hr; transdermal patch (clear or original color). Avoid immediately post-MI, in arrhythmias, or severe or worsening angina pectoris. Uncontrolled hypertension.

Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.

PITTSBURGH, October 31, 2002 -- The nearly 50 million smokers now have an effective new treatment to help them quit. The U.S. Food and Drug Administration (FDA) today approved the Commit TM Lozenge -- ...

PHILADELPHIA Future ex-smokers who utilize a nicotine-patch therapy longer may be less likely to relapse, according to a study published in Tuesday’s edition of the Annals of Internal Medicine, a ...

When quitting smoking, there are profound emotional, physiological, social and time management challenges throughout the journey. In any given year, only 3% of quit attempts succeed. NRT products for ...

Are you trying to join the non-smoking crowd? Get a free sample of NicoDerm and a $7 off coupon for NicoDerm CQ with Smart Control when you sign up by clicking on the image at right. You'll have to ...

Pfizer's smoking-cessation drug Chantix edged out GlaxoSmithKline's nicotine patch NicoDerm CQ in a study published today. The study was funded by Pfizer, and it's a bit of good news for a drug that's ...